Interestingly, CTACK and its receptor CCR10 have been shown to be upregulated in melanoma tumors and linked to inflammatory skin disorders such as psoriasis, atopy, and allergic-contact dermatitis, indicating that it may be a critical mediator of T cell-mediated skin inflammatory disorders [44]. This evidence concerns the gene CCL27 and inflammatory skin disease.